On Nov. 15, NACDS submitted a letter in response to TDCI’s request for comments on its proposed emergency adoption of rules regarding enforceable pharmacy benefit manager reform regulations.
Target reported Q3 GAAP earnings per share of $1.54, down 49.3% from $3.04 in 2021 and adjusted EPS of $1.54, a decrease of 49.1% compared with $3.03 in 2021.